Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycyl-tyrosine (Gly-Tyr) is a dipeptide consisting of glycine and tyrosine. It can arise during proteolysis of proteins or be chemically synthesized for research. While not a therapeutic target itself, Gly-Tyr is studied for its antioxidant effects and potential role as a building block in drug and nutraceutical synthesis. Its biological activity is attributed to the antioxidant nature of tyrosine within the molecule, making it of interest in research on oxidative stress, neuroprotection, and as a model compound in peptide synthesis. It has no assigned pharmacological or clinical target status and is not implicated as a causative or regulatory molecule in any known human disease processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycyl-tyrosine (Gly-Tyr).